Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results.

Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results. Gastroenterology. 2022 06; 162(7):1876-1890.

View in: PubMed

subject areas

Adalimumab
Adult
C-Reactive Protein
Crohn Disease
Dose-Response Relationship, Drug
Double-Blind Method
Humans
Remission Induction
Treatment Outcome

authors with profiles

Stephen B. Hanauer